Inhaler testing specialist Copley Scientific has announced the appointment of Paul Martin as Head of Business Development. Martin, who has extensive experience in business development within the OINDP space, was most recently Associate Director of Business Development at Intertek Melbourn. Prior to joining Intertek in 2019, he worked in business development roles at several companies, including GSK and Pharmaserve NW.
Copley Scientific CEO Jamie Clayton commented, “I’m delighted to welcome Paul to the Copley team. We already know him well from his time at Intertek Melbourn and we’re confident he’s a great fit. We look forward to working with Paul and I know he’s eager to develop productive relationships with our customers, many of whom will have met him already.”
Martin said, “If you work with inhaled products then you know Copley. It’s great to be joining a company that combines a strong heritage with an innovative, forward-looking approach. I’m excited to begin supporting customers with solutions that truly make a difference.”
Copley has launched several new products this year, including the new Inhalytix+ cascade impactor software package, the Powder Testing Workstation PTW for flowability testing, and the Powder Testing Assistant PTA 100i.
Read the Copley Scientific press release
